BNP PARIBAS FINANCIAL MARKETS - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 47 filers reported holding CIDARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$333
-16.5%
3530.0%0.00%
Q2 2023$399
-10.9%
3530.0%0.00%
Q1 2023$448
+67.8%
3530.0%0.00%
Q4 2022$267
-99.9%
3530.0%0.00%
Q3 2022$222,000
+29.1%
3530.0%0.00%
Q2 2022$172,000
-41.5%
3530.0%0.00%
Q1 2022$294,000
-56.8%
353
-34.1%
0.00%
Q4 2021$681,000
-57.2%
536
-24.5%
0.00%
Q3 2021$1,590,000
+10.9%
7100.0%0.00%
Q2 2021$1,434,000
-91.1%
710
-88.3%
0.00%
Q1 2021$16,120,000
+27.4%
6,060
-4.3%
0.00%
Q4 2020$12,658,000
-42.2%
6,329
-17.7%
0.00%
Q3 2020$21,914,000
+373.9%
7,689
+513.6%
0.00%
Q2 2020$4,624,000
+92380.0%
1,253
+62550.0%
0.00%
Q1 2020$5,000
-37.5%
20.0%0.00%
Q4 2019$8,000
+33.3%
2
-33.3%
0.00%
Q3 2019$6,000
+20.0%
30.0%0.00%
Q2 2019$5,000
-37.5%
30.0%0.00%
Q1 2019$8,000
+14.3%
30.0%0.00%
Q4 2018$7,000
-46.2%
30.0%0.00%
Q3 2018$13,000
-18.8%
30.0%0.00%
Q2 2018$16,000
+33.3%
30.0%0.00%
Q1 2018$12,000
-40.0%
30.0%0.00%
Q4 2017$20,000
-16.7%
30.0%0.00%
Q3 2017$24,000
+4.3%
30.0%0.00%
Q2 2017$23,000
-95.2%
3
-95.2%
0.00%
Q1 2017$484,000
-78.8%
62
-71.7%
0.00%
Q4 2016$2,278,000
-72.7%
219
-70.0%
0.00%
Q3 2016$8,359,000
+90.8%
730
+71.8%
0.00%
Q2 2016$4,382,000
-72.0%
425
-53.4%
0.00%
Q4 2015$15,650,000
+23.7%
912
-8.3%
0.00%
Q3 2015$12,656,0009950.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,677,194$819,0001.02%
BVF INC/IL 6,861,127$3,352,0000.16%
5AM Venture Management, LLC 1,134,511$554,0000.14%
Knott David M Jr 635,254$310,0000.13%
Nantahala Capital Management 4,819,090$2,355,0000.12%
West Family Investments, Inc. 368,910$180,0000.07%
Stonepine Capital Management, LLC 208,443$102,0000.05%
JEPPSON WEALTH MANAGEMENT, LLC 181,075$88,0000.04%
Ground Swell Capital, LLC 11,397$6,0000.01%
Point72 Asset Management, L.P. 4,200,000$2,052,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders